EUCTR2006-006742-34-GB进行中（未招募）1 期
The effect of Ezetimibe or pyridoxine in Patients with Primary Biliary Cirrhosis.
Barts and The London NHS Trust0 个研究点目标入组 0 人开始时间: 2007年6月3日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •1. All patients with diagnosis of PBC.
- •2. Aged over 19yo.
- •3. Male and Female.
- •4. Able to give consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Patients with other causes of liver disease.
- •2. Patients who are recruited and taking part in another reseach study.
- •3. Patients who are unable to give informed consent.
- •a. Adults with learning disabilities
- •b. Children under 16
- •c. Females who are pregnant or lactating.
- •d. Adults who are unconscious or very severely ill
- •e. Adults who have a terminal illness
- •f. Patients with a diagnosis of cancer.
- •g. Adults in emergency situations
- •h. Adults with serious mental illness
- •i. Adults with dementia
- •j. Prisoners
- •4. Patients on statin, fibrate, ciclosporin
- •5. Patients with rare hereditary problems of galactose intolerance
研究者
相似试验
已完成
不适用
A study on efficacy of Ezetimibe in patients with Dyslipidemia associated with Digestive disease-Its effect on biliary bigly metabolismhypercholesterolemiaJPRN-UMIN000004183Hiroshima University hospital Department of General Medicine60
招募中
不适用
Effects of ezetimibe combination therapy for patients with atherosclerotic cardiovascular disease; randomized comparison of LDL-cholesterol targeting <70 versus <55mg/dL; Ez-PAVE trialDiseases of the circulatory systemKCT0005547Yonsei University Health System, Severance Hospital3,048
已完成
不适用
Combination therapy with Ezetimibe and Gemfibrozile on post-prandial hypertriglyceridemiaDiabetes.Non-insulin-dependent diabetes mellitusIRCT201105311179N5Zanjan Metabolic Research Center, Zanjan University of medical science90
已完成
3 期
Therapeutic fficacy of ezetimibe in patients with nonalcoholic steatohepatitis (NASH): a pilot study.onalcoholic steatohepatitis (NASH)JPRN-UMIN000001258Division of Gastroenterology, Yokohama City University Hospital10
已完成
不适用
Efficacy of Ezetimibe for the patients with Non-alcoholic fatty liver disease (NAFLD)JPRN-UMIN000001071Osaka City University Graduate School of Medicine60